Regulations.gov document: Reauthorization of the Biosimilar User Fee Act; Public Meeting; Request for Comments

retained text

Query: data center
Agency: FDA
Type: Notice
Docket: FDA-2015-N-3326
Comment end: 2026-11-26T04:59:59Z

document fetched 2026-09-28 02:43 · canonical https://regulations.gov/document/FDA-2015-N-3326-0056